CellaVision

120,60 SEK

+0,67%

1.477 følger denne virksomhed

CEVI

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for CellaVision

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2024

EV/EBIT

Medianen 2019-2024

Udbytteprocent

Medianen 2019-2025

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (SEK)319,50307,00325,20229,00212,00217,50157,20
Aktier23,923,923,923,923,923,923,9
Markedsværdi7.620,77.322,67.756,75.462,05.056,55.187,73.749,5
Enterprise value7.678,57.353,17.763,05.456,54.999,65.065,1-
EV/S16,615,613,78,57,47,0-
EV/EBITDA52,351,539,627,624,223,1-
EV/EBIT60,766,747,734,529,928,5-
P/E76,881,861,946,238,836,924,5
P/B21,8817,0414,288,517,066,364,22
P/S16,515,513,78,57,57,24,9
Udbytteprocent0,0 %0,2 %0,6 %0,9 %1,1 %1,2 %1,8 %
Equity ratio54,3 %64,3 %65,8 %72,0 %77,1 %80,6 %81,1 %
Gearing ratio45,9 %30,9 %25,2 %16,0 %9,0 %3,3 %2,9 %